Xarelto: Reduction in the risk of stroke and other major cardiovascular events
Debra Laurent MN, ARNP
Debra Laurent is a local ARNP with years of experience in Cardiovascular medicine. She will be presenting on the use of Rivaroxaban (Xarelto) in the reduction of risk for stroke and other major cardiovascular events across thrombotic conditions in patients with non-valvular atrial fibrillation or chronic CAD/PAD
Interested In Attending This Event?
Additional Registration Information:
Please RSVP directly with the Janssen. Remember if your plans change, to contact Janssen directly. It is our attention to these details that allows PSNPA to have such great program hosts.